Ibex co-founder and CEO Joseph (Yossi) Mossel joins Dennis Strenk on his podcast, People of Pathology. Listen below to hear Yossi and Chaim Linhart’s journey to found the company, the impact Ibex is having today on cancer diagnostics, and the mission that has guided our team since day 1.
Podcast: Revolutionizing pathology with AI: A conversation with Ibex Co-Founder – Joseph Mossel
Share this article:
Share this article:
Subscribe to our newsletter:
By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.
About IBEX
IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.
Subscribe to our newsletter:
By providing my details I agree that my data will be handled in accordance with IBEX Privacy Policy.